BigHat Biosciences AI/ML antibody discovery collaboration
Research partnerships Announcement
Disclosed: Verified: Partners: BigHat Biosciences
AbbVie and BigHat announced a research collaboration using BigHat's AI/ML-guided Milliner platform to discover next-generation antibodies in oncology and neuroscience, with a $30 million upfront payment.